US45168D1046 - IDXX - 888210 (XNAS)
IDEXX LABORATORIES INC Share
412,26 USD
Value change
Data point: | () |
Portfolio value (at data point, {date}) | |
Portfolio value (at the start of the period, n/a) | - |
Value change | |
Value change % |
Loading chart data…
IDEXX LABORATORIES INC
New Comparison Value
Current Prices from IDEXX LABORATORIES INC
Exchange | Ticker | Currency | Last Trade | Price | Daily Change | Daily Change % |
---|---|---|---|---|---|---|
NASDAQ |
IDXX
|
USD
|
20.12.2024 22:04
|
412,26 USD
| 409,03 USD | 0,79 % |
London |
0J8P.L
|
USD
|
20.12.2024 16:56
|
408,73 USD
| 409,03 USD | -0,07 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | -4,59 % | -1,50 % | -18,64 % | -16,84 % | -25,49 % | 57,62 % |
Company Profile for IDEXX LABORATORIES INC Share
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Invested Funds
The following funds have invested in: IDEXX LABORATORIES INC invested:
Fund | Vol. in million 1.822,78 | Percentage (%) 3,26 % |
Fund | Vol. in million 19.144,16 | Percentage (%) 1,22 % |
Fund | Vol. in million 2.647,83 | Percentage (%) 0,77 % |
Fund | Vol. in million 3.121,49 | Percentage (%) 0,77 % |
Fund | Vol. in million 2.730,80 | Percentage (%) 0,75 % |
Company Data for IDEXX LABORATORIES INC Share
Name IDEXX LABORATORIES INC
Company IDEXX Laboratories, Inc.
Symbol IDXX
Website https://www.idexx.com
Primary Exchange
NASDAQ
WKN 888210
ISIN US45168D1046
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Mr. Jonathan J. Mazelsky
Market Capitalization 37 Mrd.
Country United States of America
Currency USD
Employees 11,0 T
Address One IDEXX Drive, 04092 Westbrook
IPO Date 1991-06-21
Stock Splits
Date | Split |
---|---|
16.06.2015 | 2:1 |
27.11.2007 | 2:1 |
06.06.1995 | 2:1 |
04.10.1993 | 2:1 |
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | IX1.F |
London | 0J8P.L |
NASDAQ | IDXX |
XETRA | IX1.DE |
More Shares
Investors who IDEXX LABORATORIES INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.